Cellular microparticles: new players in the field of vascular disease?
about
Tissue factor and its natural inhibitor in pre-eclampsia and SGAHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsActivation of blood coagulation in cancer: implications for tumour progressionMicroparticles as mediators and biomarkers of rheumatic diseaseThe biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progressionEffects of matrix metalloproteinases on the fate of mesenchymal stem cellsMicrovesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAsDetection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing.Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial.The role of endothelial cell apoptosis in inflammatory and immune diseases.Circulating apoptotic progenitor cells in patients with congestive heart failure.Complement activation on platelets: implications for vascular inflammation and thrombosis.PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.Circulating endothelial microparticles involved in lung function decline in a rat exposed in cigarette smoke maybe from apoptotic pulmonary capillary endothelial cellsThe involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation.Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy.Flow cytometric identification and functional characterization of immature and mature circulating endothelial cellsMicroparticle-mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells.Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.Elevated levels of procoagulant plasma microvesicles in dialysis patients.Selenium prevents microparticle-induced endothelial inflammation in patients after cardiopulmonary resuscitationThrombosis in inflammatory bowel diseases: what's the link?Introduction to haemostasis from a pharmacodynamic perspectiveEndothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling.Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation processIsolation and phenotypic characteristics of microparticles in acute respiratory distress syndrome.Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria.Mononuclear Phagocyte-Derived Microparticulate Caspase-1 Induces Pulmonary Vascular Endothelial Cell Injury.Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitationDetermination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidicsYear in review 2010: Critical Care--Cardiac arrest and cardiopulmonary resuscitationIn vitro Incubation of Platelets with oxLDL Does Not Induce Microvesicle Release When Measured by Sensitive Flow CytometryThe how and why of exocytic vesicles.Inflammation and coagulation in inflammatory bowel disease: The clot thickens.Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Microparticles as novel biomarkers and therapeutic targets in coronary heart disease.Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients.Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.Obesity and sexual dysfunction, male and female.
P2860
Q24323351-619D22E1-F039-4CC2-B539-B29B0218B8B7Q26774658-1470E110-2877-42C0-8319-AEB58A6C0621Q26998742-87C1C44D-BD1B-4BF3-AB62-CD88752E8EC5Q27016054-F8679C4D-E1D6-44F6-A62F-AC2EAF261E7AQ28066054-5B7B6C5F-A8C1-47A2-A322-466AD40835A2Q28074717-7ED9CCAA-71A2-4F65-A32A-C781A5171E51Q28750201-2D72C526-D8FE-4AED-8314-ED6681687099Q30433778-5C5A6480-AEC8-4B5F-A728-119EEE64CE31Q30754485-04F28221-61C2-4F28-95A6-597381993FF6Q33367867-E34E78EC-4BC9-43AC-B118-598BD44C841FQ33370283-8124E696-742B-425D-96FB-D93A1F829799Q33390662-D3904C1A-1AD1-46DB-86A3-C3F1527E3A00Q33400120-63F77698-ADE1-4A18-9582-286C90F88F66Q33814681-25689019-75E1-4533-B32C-8627CBF4BD2FQ33916623-8D2BC4FC-8947-411B-883D-78F118988356Q34026956-357B2ECB-071B-45D4-A3BB-7BD11CE0AAA8Q34158605-7C864AE6-5E43-47F1-9F7C-6F3C1E5BD1ECQ34250011-26F95D30-AA20-490C-A27D-A018B193EFF3Q34533653-E660FAF3-CE18-4548-BB12-C3174800BEA7Q34579752-32FBF582-9EE3-4BCB-954C-659C5CB9C002Q34927281-E33B706D-33AC-426B-8289-58B2C4EBDAC8Q35200866-48460CBA-E77C-4A5E-BA65-C2B1C82B6492Q35368162-A77FB854-7D5F-4F32-8427-E574DD03326FQ35373597-7F3C84DF-DA93-420A-8302-5D869E6F8222Q35489022-8AFFC447-B3C7-4BB5-9FDF-03EFE7C0FA41Q35576279-815CF43A-4133-4FEF-A41D-5D1F171AE12DQ35631232-A09F3564-3AF7-4760-BCA3-34138B4BD224Q35664136-78238614-D6F7-40A5-9B29-B68831964B37Q35879582-77C4348F-5B32-4E7B-A8B6-C284330A4053Q35908304-417B673A-0677-4893-8DBA-F19E2745F39AQ36072064-10DF59CF-BE89-4764-A074-1A216BC62C28Q36073084-DCABE50C-9F0D-4B81-B515-7D27B792CA94Q36351154-F4E90608-E978-41C2-96F4-DA8E4EFAD8AAQ36362785-59019FCC-107E-4D54-8F69-4761AE8E0DB6Q36652262-59AFFC8F-B9C4-46EB-A11C-B79E9663337CQ36745194-6D654C2D-552C-41A0-9753-9B12D104FA4EQ36816361-646886DF-83D0-4B5D-B5A1-849715215D22Q36947164-9153688B-EB72-43A2-9A6E-DD2167308628Q37071701-6AE36956-B4EE-4249-BED1-460FF0D69AFBQ37133986-5AD37512-BBAF-48C8-81C8-2135583372A9
P2860
Cellular microparticles: new players in the field of vascular disease?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cellular microparticles: new players in the field of vascular disease?
@ast
Cellular microparticles: new players in the field of vascular disease?
@en
type
label
Cellular microparticles: new players in the field of vascular disease?
@ast
Cellular microparticles: new players in the field of vascular disease?
@en
prefLabel
Cellular microparticles: new players in the field of vascular disease?
@ast
Cellular microparticles: new players in the field of vascular disease?
@en
P2093
P1476
Cellular microparticles: new players in the field of vascular disease?
@en
P2093
P304
P356
10.1111/J.1365-2362.2004.01355.X
P577
2004-06-01T00:00:00Z